JOHN P BRANCACCIO
CIK 1276551 · Chairman · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$127.9K
Companies
10
Total Filings
66
Lifetime Open-Market Net
$107.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OKYO | Director | 16,670 | $1.52 | $25.3K | $25.0K | 2 | 2026-06-10 |
| HEPA | Chairman | 7,008 | $0.08 | $561 | $10.7K | 6 | 2024-02-21 |
| CRDF | Director | 12,260 | $1.54 | $18.9K | $42.8K | 6 | 2022-06-09 |
| Cardiff Oncology, Inc. (TROV) Delisted | Director | 13,598 | — | — | $16.0K | 7 | 2019-06-24 |
| SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Director | 116,571 | — | — | $23.3K | 5 | 2018-07-06 |
| Hepion Pharmaceuticals, Inc. (CTRV) Delisted | Director | — | — | — | $0 | 2 | 2018-07-03 |
| Cardiff Oncology, Inc. (TROVW) Delisted | Director | — | — | — | $0 | 7 | 2017-01-05 |
| SYNERGY PHARMACEUTICALS, INC. (SGYPW) Delisted | Director | 21,883 | — | — | -$14.5K | 11 | 2016-09-21 |
| ACEL | Director | 6,300 | $13.20 | $83.2K | $4.5K | 5 | 2009-01-05 |
| CALLISTO PHARMACEUTICALS INC (KAL) Delisted | Director | — | $1.12 | — | $0 | 1 | 2007-09-28 |
Recent Filings · Page 2 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-19 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2020-05-18 | CRDF | Buy (P) | +6,993 | $10.0K | EDGAR |
| 2020-04-07 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2019-07-25 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2019-06-24 | Cardiff Oncology, Inc. (TROV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-06 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Mixed | +36,127 | $25.0K | EDGAR |
| 2018-07-03 | Hepion Pharmaceuticals, Inc. (CTRV) Delisted | Buy (P) | — | $0 | EDGAR |
| 2018-06-19 | SYNERGY PHARMACEUTICALS, INC. (SGYP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-13 | Cardiff Oncology, Inc. (TROV) Delisted | Buy (P) | +10,000 | $8.0K | EDGAR |
| 2018-06-11 | Cardiff Oncology, Inc. (TROV) Delisted | Buy (P) | +10,000 | $8.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.